8 Comments

I like your attitude here, fairness comes through loud and clear.

I wish there was a way to force Merck to do the study as early treatment using IVM in the control, because fuck everybody who Pfizered IVM off the table and the propagandists who created the spectre of horse de wormer in the minds of the people.

Expand full comment
author

Unfortunately IVM not receiving approval means it couldn't be used as a reference therapeutic. It puts the studies in a strange position, because when you only provide a therapeutic in one group and not in another, especially during early treatment, it's easy to say "hey, our drug works! Giving something is better than nothing!"

If clinical trials indicated that IVM and HCQ aren't effective after several studies then yes, we can probably argue against it but it is well established that early treatment is the best time to offer treatment.

I'm not a doctor, but it's extremely concerning that doctors are being barred for doing what they think will help instead of sitting around till you can't breathe.

Expand full comment

The horror is across the board - doctors being kept from the practice of medicine especially.

Expand full comment
author

Well it makes me think of interviews Dr. Drew has done where he kept saying that the FDA and the CDC never got in the way of how doctors treated patients (until now) and so it's quite shocking to see that doctors are told to do nothing and hope people don't die.

Expand full comment

In Australia I can understand that working, as the vast majority of doctor income is medicare. Is it the same in the US? Can CDC/FDA/Feds pull funding from doctors if they don't toe the line?

Expand full comment

I'm having a hard time with the idea that anyone would even consider using Molnupiravir as a prophylactic.

Expand full comment
author

I honestly don't see it being a possibility, but if it does that'd seem like huge oversight and I'd really call into question why that would be allowed to happen. One of the only mutagenic drugs that is on the market is ribavirin, but even that drug has such a narrow window of usage, and it certainly doesn't seem to be recommended as a prophylactic.

Expand full comment